메뉴 건너뛰기




Volumn 33, Issue 5, 2013, Pages 1899-1912

Mutations in adenosine deaminase-like (ADAL) protein confer resistance to the antiproliferative agents N6-cyclopropyl-PMEDAP and GS-9219

Author keywords

ADAL; Deamination; GS 9219; PMEG

Indexed keywords

ADENOSINE DEAMINASE; GS 9219; PRODRUG; UNCLASSIFIED DRUG;

EID: 84878197139     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (6)

References (41)
  • 2
    • 0032555639 scopus 로고    scopus 로고
    • Incorporation and excision of 9-(2-phosphonylmethoxyethyl)guanine (PMEG) by DNA polymerase delta and epsilon in vitro
    • DOI 10.1074/jbc.273.34.21966
    • Kramata P, Downey KM and Paborsky LR: Incorporation and excision of 9-(2-phosphonylmethoxyethyl)guanine (PMEG) by DNA polymerase delta and epsilon in vitro. J Biol Chem 273: 21966-21971, 1998. (Pubitemid 28405376)
    • (1998) Journal of Biological Chemistry , vol.273 , Issue.34 , pp. 21966-21971
    • Kramata, P.1    Downey, K.M.2    Paborsky, L.R.3
  • 3
    • 66649100502 scopus 로고    scopus 로고
    • Targeting DNA repair in chronic lymphocytic leukemia cells with a novel acyclic nucleotide analogue, GS-9219
    • Tsai CY, Ray AS, Tumas DB, Keating MJ, Reiser H and Plunkett W: Targeting DNA repair in chronic lymphocytic leukemia cells with a novel acyclic nucleotide analogue, GS-9219. Clin Cancer Res 15: 3760-3769, 2009.
    • (2009) Clin Cancer Res , vol.15 , pp. 3760-3769
    • Tsai, C.Y.1    Ray, A.S.2    Tumas, D.B.3    Keating, M.J.4    Reiser, H.5    Plunkett, W.6
  • 4
    • 0033567434 scopus 로고    scopus 로고
    • 6-cyclopropyl-2,6-diaminopurine (cpr-PMEDAP) as a prodrug of 9-(2-phosphonylmethoxyethyl)guanine (PMEG)
    • 6-cyclopropyl-2,6-diaminopurine (cpr-PMEDAP) as a prodrug of 9-(2-phosphonylmethoxyethyl)guanine (PMEG). Biochem Pharmacol 58: 709-714, 1999.
    • (1999) Biochem Pharmacol , vol.58 , pp. 709-714
    • Compton, M.L.1    Toole, J.J.2    Paborsky, L.R.3
  • 5
    • 0033564975 scopus 로고    scopus 로고
    • 6-cyclopropyl-PMEDAP: A novel derivative of 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP) with distinct metabolic, antiprolife-rative, and differentiation-inducing properties
    • 6- cyclopropyl-PMEDAP: A novel derivative of 9-(2-phosphonylmethoxyethyl)-2,6- diaminopurine (PMEDAP) with distinct metabolic, antiprolife-rative, and differentiation-inducing properties. Biochem Pharmacol 58: 311-323, 1999.
    • (1999) Biochem Pharmacol , vol.58 , pp. 311-323
    • Hatse, S.1    Naesens, L.2    De Clercq, E.3    Balzarini, J.4
  • 8
    • 0034672616 scopus 로고    scopus 로고
    • Interaction of guanine phosphonomethoxyalkyl derivatives with GMP kinase isoenzymes
    • Krejcova R, Horska K, Votruba I and Holy A: Interaction of guanine phosphonomethoxyalkyl derivatives with GMP kinase isoenzymes. Biochem Pharmacol 60: 1907-1913, 2000.
    • (2000) Biochem Pharmacol , vol.60 , pp. 1907-1913
    • Krejcova, R.1    Horska, K.2    Votruba, I.3    Holy, A.4
  • 9
    • 79958174504 scopus 로고    scopus 로고
    • Point mutations in human guanylate kinase account for acquired resistance to anticancer nucleotide analogue PMEG
    • Mertlikova-Kaiserova H, Rumlova M, Tloustova E, Prochazkova E, Holy A and Votruba I: Point mutations in human guanylate kinase account for acquired resistance to anticancer nucleotide analogue PMEG. Biochem Pharmacol 82: 131-138, 2011.
    • (2011) Biochem Pharmacol , vol.82 , pp. 131-138
    • Mertlikova-Kaiserova, H.1    Rumlova, M.2    Tloustova, E.3    Prochazkova, E.4    Holy, A.5    Votruba, I.6
  • 11
    • 0026755636 scopus 로고
    • Cellular metabolism and enzymatic phosphorylation of 9-(2- phosphonylmethoxyethyl) guanine (PMEG), a potent antiviral agent
    • Ho HT, Woods KL, Konrad SA, De Boeck H and Hitchcock MJ: Cellular metabolism and enzymatic phosphorylation of 9-(2-phosphonylmethoxyethyl) guanine (PMEG), a potent antiviral agent. Adv Exp Med Biol 312: 159-166, 1992.
    • (1992) Adv Exp Med Biol , vol.312 , pp. 159-166
    • Ho, H.T.1    Woods, K.L.2    Konrad, S.A.3    De Boeck, H.4    Hitchcock, M.J.5
  • 12
    • 0014248511 scopus 로고
    • Survey of animal neoplasms in Alameda and Contra Costa Counties, California. II. Cancer morbidity in dogs and cats from Alameda County
    • Dorn CR, Taylor DO, Schneider R, Hibbard HH and Klauber MR: Survey of animal neoplasms in Alameda and Contra Costa Counties, California. II. Cancer morbidity in dogs and cats from Alameda County. J Natl Cancer Inst 40: 307-318, 1968.
    • (1968) J Natl Cancer Inst , vol.40 , pp. 307-318
    • Dorn, C.R.1    Taylor, D.O.2    Schneider, R.3    Hibbard, H.H.4    Klauber, M.R.5
  • 13
    • 37349034010 scopus 로고    scopus 로고
    • Canine Lymphoma and Lymphoid Leukemia
    • Withrow SJ, Vail DM (eds.). St. Louis, Mo.: Saunders Elsevier
    • Vail DM and Young KM: Canine Lymphoma and Lymphoid Leukemia. In: Withrow & MacEwen's Small Animal Clinical Oncology. Withrow SJ, Vail DM (eds.). St. Louis, Mo.: Saunders Elsevier, pp. 699-733, 2007.
    • (2007) Withrow & MacEwen's Small Animal Clinical Oncology , pp. 699-733
    • Vail, D.M.1    Young, K.M.2
  • 14
    • 33750349768 scopus 로고    scopus 로고
    • Dexamethasone, melphalan, actinomycin D, cytosine arabinoside (DMAC) protocol for dogs with relapsed lymphoma
    • DOI 10.1892/0891-6640(2006)20[1178:DMADCA]2.0.CO;2
    • Alvarez FJ, Kisseberth WC, Gallant SL and Couto CG: Dexamethasone, melphalan, actinomycin D, cytosine arabinoside (DMAC) protocol for dogs with relapsed lymphoma. J Vet Intern Med 20: 1178-1183, 2006. (Pubitemid 44621049)
    • (2006) Journal of Veterinary Internal Medicine , vol.20 , Issue.5 , pp. 1178-1183
    • Alvarez, F.J.1    Kisseberth, W.C.2    Gallant, S.L.3    Couto, C.G.4
  • 16
    • 0028512653 scopus 로고
    • Actinomycin D for reinduction of remission in dogs with resistant lymphoma
    • Moore AS, Ogilvie GK and Vail DM: Actinomycin D for reinduction of remission in dogs with resistant lymphoma. J Vet Intern Med 8: 343-344, 1994.
    • (1994) J Vet Intern Med , vol.8 , pp. 343-344
    • Moore, A.S.1    Ogilvie, G.K.2    Vail, D.M.3
  • 19
    • 0014186966 scopus 로고
    • A novel method for phosphorylation of nucleosides to 5′-nucleotides
    • Yoshikawa M, Kato T and Takenishi T: A novel method for phosphorylation of nucleosides to 5′-nucleotides. Tetrahedron Lett 50: 5065-5068, 1967.
    • (1967) Tetrahedron Lett , vol.50 , pp. 5065-5068
    • Yoshikawa, M.1    Kato, T.2    Takenishi, T.3
  • 22
    • 0041935939 scopus 로고    scopus 로고
    • Institutes of Health, Bethesda, Maryland, USA
    • Rasband WS: ImageJ, Institutes of Health, Bethesda, Maryland, USA, http://imagej.nih.gov/ij/, 1997-2011.
    • (1997) ImageJ
    • Rasband, W.S.1
  • 23
    • 0027398949 scopus 로고
    • A pre-transition-state mimic of an enzyme: X-ray structure of adenosine deaminase with bound 1-deazaadenosine and zinc-activated water
    • Wilson DK and Quiocho FA: A pre-transition-state mimic of an enzyme: X-ray structure of adenosine deaminase with bound 1-deazaadenosine and zinc-activated water. Biochemistry 32: 1689-1694, 1993. (Pubitemid 23066441)
    • (1993) Biochemistry , vol.32 , Issue.7 , pp. 1689-1694
    • Wilson, D.K.1    Quiocho, F.A.2
  • 24
    • 0030278180 scopus 로고    scopus 로고
    • Monoclonal antibody C219 immunohistochemistry against P-glycoprotein: Sequential analysis and predictive ability in dogs with lymphoma
    • Bergman PJ, Ogilvie GK and Powers BE: Monoclonal antibody C219 immunohistochemistry against P-glycoprotein: Sequential analysis and predictive ability in dogs with lymphoma. J Vet Intern Med 10: 354-359, 1996. (Pubitemid 126701152)
    • (1996) Journal of Veterinary Internal Medicine , vol.10 , Issue.6 , pp. 354-359
    • Bergman, P.J.1    Ogilvie, G.K.2    Powers, B.E.3
  • 25
    • 0030227521 scopus 로고    scopus 로고
    • Immunohistochemical detection of P-glycoprotein in formalin-fixed and paraffin-embedded normal and neoplastic canine tissues
    • Ginn PE: Immunohistochemical detection of P-glycoprotein in formalin-fixed and paraffin-embedded normal and neoplastic canine tissues. Vet Pathol 33: 533-541, 1996.
    • (1996) Vet Pathol , vol.33 , pp. 533-541
    • Ginn, P.E.1
  • 26
    • 0029965253 scopus 로고    scopus 로고
    • P-glycoprotein expression in canine lymphoma: A relevant, intermediate model of multidrug resistance
    • DOI 10.1002/(SICI)1097-0142(19960501)77:9<1892::AI
    • Lee JJ, Hughes CS, Fine RL and Page RL: P-glycoprotein expression in canine lymphoma: A relevant, intermediate model of multidrug resistance. Cancer 77: 1892-1898, 1996. (Pubitemid 26125192)
    • (1996) Cancer , vol.77 , Issue.9 , pp. 1892-1898
    • Lee, J.J.1    Hughes, C.S.2    Fine, R.L.3    Page, R.L.4
  • 27
    • 0029130028 scopus 로고
    • The expression of P-glycoprotein in canine lymphoma and its association with multidrug resistance
    • Moore AS, Leveille CR, Reimann KA, Shu H and Arias IM: The expression of P-glycoprotein in canine lymphoma and its association with multidrug resistance. Cancer Invest 13: 475-479, 1995.
    • (1995) Cancer Invest , vol.13 , pp. 475-479
    • Moore, A.S.1    Leveille, C.R.2    Reimann, K.A.3    Shu, H.4    Arias, I.M.5
  • 28
    • 36849005953 scopus 로고    scopus 로고
    • Multidrug resistance in cancer: Its mechanism and its modulation
    • DOI 10.1358/dnp.2007.20.6.1141496
    • Pauwels EK, Erba P, Mariani G and Gomes CM: Multidrug resistance in cancer: Its mechanism and its modulation. Drug News Perspect 20: 371-377, 2007. (Pubitemid 350219069)
    • (2007) Drug News and Perspectives , vol.20 , Issue.6 , pp. 371-377
    • Pauwels, E.K.J.1    Erba, P.2    Mariani, G.3    Gomes, C.M.F.4
  • 29
    • 2442696471 scopus 로고    scopus 로고
    • Multidrug resistance protein (MRP) 4- and MRP 5-mediated efflux of 9-(2-phosphonylmethoxyethyl)adenine by microglia
    • DOI 10.1124/jpet.103.063966
    • Dallas S, Schlichter L and Bendayan R: Multidrug-resistance protein (MRP) 4- and MRP 5-mediated efflux of 9-(2-phosphonylmethoxyethyl)adenine by microglia. J Pharmacol Exp Ther 309: 1221-1229, 2004. (Pubitemid 38669713)
    • (2004) Journal of Pharmacology and Experimental Therapeutics , vol.309 , Issue.3 , pp. 1221-1229
    • Dallas, S.1    Schlichter, L.2    Bendayan, R.3
  • 30
    • 34250882212 scopus 로고    scopus 로고
    • Experimental therapy with 9-[2-(Phosphonomethoxy)ethyl]-2, 6-diaminopurine (PMEDAP): Origin of resistance
    • Zapotocky M, Hanzalova J, Starkova J, Votruba I, Holy A and Otova B: Experimental therapy with 9-[2-(phosphonomethoxy) ethyl]-2,6-diaminopurine (PMEDAP): Origin of resistance. Folia Biol 53: 79-84, 2007. (Pubitemid 46979029)
    • (2007) Folia Biologica , vol.53 , Issue.3 , pp. 79-84
    • Zapotocky, M.1    Hanzalova, J.2    Starkova, J.3    Votruba, I.4    Holy, A.5    Otova, B.6
  • 31
    • 0019376933 scopus 로고
    • Biochemistry of diseases of immunodevelopment
    • Martin DW Jr. and Gelfand EW: Biochemistry of diseases of immunodevelopment. Annu Rev Biochem 50: 845-877, 1981.
    • (1981) Annu Rev Biochem , vol.50 , pp. 845-877
    • Martin Jr., D.W.1    Gelfand, E.W.2
  • 32
    • 28244477635 scopus 로고    scopus 로고
    • Phylogenetic analysis reveals a novel protein family closely related to adenosine deaminase
    • DOI 10.1007/s00239-005-0046-y
    • Maier SA, Galellis JR and McDermid HE: Phylogenetic analysis reveals a novel protein family closely related to adenosine deaminase. J Mol Evol 61: 776-794, 2005. (Pubitemid 41706026)
    • (2005) Journal of Molecular Evolution , vol.61 , Issue.6 , pp. 776-794
    • Maier, S.A.1    Galellis, J.R.2    McDermid, H.E.3
  • 33
    • 4043137442 scopus 로고    scopus 로고
    • Purine nucleoside antimetabolites in development for the treatment of cancer
    • Parker WB, Secrist JA, 3rd and Waud WR: Purine nucleoside antimetabolites in development for the treatment of cancer. Curr Opin Investig Drugs 5: 592-596, 2004.
    • (2004) Curr Opin Investig Drugs , vol.5 , pp. 592-596
    • Parker, W.B.1    Secrist III, J.A.2    Waud, W.R.3
  • 34
    • 18844403641 scopus 로고    scopus 로고
    • Nelarabine: A nucleoside analog with efficacy in T-cell and other leukemias
    • Kisor DF: Nelarabine: A nucleoside analog with efficacy in T-cell and other leukemias. Ann Pharmacother 39: 1056-1063, 2005.
    • (2005) Ann Pharmacother , vol.39 , pp. 1056-1063
    • Kisor, D.F.1
  • 38
    • 0021816217 scopus 로고
    • Identification of a point mutation in the adenosine deaminase gene responsible for immunodeficiency
    • Bonthron DT, Markham AF, Ginsburg D and Orkin SH: Identification of a point mutation in the adenosine deaminase gene responsible for immunodeficiency. J Clin Invest 76: 894-897, 1985. (Pubitemid 15023151)
    • (1985) Journal of Clinical Investigation , vol.76 , Issue.2 , pp. 894-897
    • Bonthron, D.T.1    Markham, A.F.2    Ginsburg, D.3    Okrin, S.H.4
  • 39
    • 0024508043 scopus 로고
    • Identification of a point mutation resulting in a heat-labile adenosine deaminase (ADA) in two unrelated children with partial ADA deficiency
    • Hirschhorn R, Tzall S, Ellenbogen A and Orkin SH: Identification of a point mutation resulting in a heat-labile adenosine deaminase (ADA) in two unrelated children with partial ADA deficiency. J Clin Invest 83: 497-501, 1989. (Pubitemid 19061169)
    • (1989) Journal of Clinical Investigation , vol.83 , Issue.2 , pp. 497-501
    • Hirschhorn, R.1    Tzall, S.2    Ellenbogen, A.3    Orkin, S.H.4
  • 40
    • 0022567152 scopus 로고
    • One adenosine deaminase allele in a patient with severe combined immunodeficiency contains a point mutation abolishing enzyme activity
    • Valerio D, Dekker BM, Duyvesteyn MG, van der Voorn L, Berkvens TM, van Ormondt H and van der Eb AJ: One adenosine deaminase allele in a patient with severe combined immunodeficiency contains a point mutation abolishing enzyme activity. EMBO J 5: 113-119, 1986.
    • (1986) EMBO J , vol.5 , pp. 113-119
    • Valerio, D.1    Dekker, B.M.2    Duyvesteyn, M.G.3    Van Der Voorn, L.4    Berkvens, T.M.5    Van Ormondt, H.6    Van Der Eb, A.J.7
  • 41
    • 0026434561 scopus 로고
    • Atomic structure of adenosine deaminase complexed with a transition-state analog: Understanding catalysis and immunodeficiency mutations
    • Wilson DK, Rudolph FB and Quiocho FA: Atomic structure of adenosine deaminase complexed with a transition-state analog: Understanding catalysis and immunodeficiency mutations. Science 252: 1278-1284, 1991. (Pubitemid 21917036)
    • (1991) Science , vol.252 , Issue.5010 , pp. 1278-1284
    • Wilson, D.K.1    Rudolph, F.B.2    Quiocho, F.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.